Menu Search
Equities

Japan Lifeline Co Ltd

7575:TYO

Japan Lifeline Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,285.00
  • Today's Change-4.00 / -0.31%
  • Shares traded76.20k
  • 1 Year change+15.25%
  • Beta0.5079
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Japan Lifeline Co Ltd had relatively flat revenues (51.75bn to 51.38bn), though the company grew net income 9.04% from 6.89bn to 7.52bn. A reduction in the cost of goods sold as a percentage of sales from 42.23% to 39.70% was a component in the net income growth despite flat revenues.
Gross margin60.32%
Net profit margin14.60%
Operating margin21.52%
Return on assets11.33%
Return on equity14.38%
Return on investment14.02%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at Japan Lifeline Co Ltd fell by 5.69bn. However, the company earned 6.92bn from its operations for a Cash Flow Margin of 13.46%. In addition the company used 4.06bn on investing activities and also paid 8.55bn in financing cash flows.
Cash flow per share130.34
Price/Cash flow per share10.20
Book value per share779.23
Tangible book value per share749.21
More ▼

Balance sheet in JPYView more

Japan Lifeline Co Ltd has a Debt to Total Capital ratio of 8.85%, a higher figure than the previous year's 0.54%.
Current ratio2.78
Quick ratio1.62
Total debt/total equity0.0971
Total debt/total capital0.0885
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 10.53% and 11.91%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)2.97%
Div growth rate (5 year)7.69%
Payout ratio (TTM)39.84%
EPS growth(5 years)0.5925
EPS (TTM) vs
TTM 1 year ago		15.84
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.